DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Wassmann B, Gökbuget N, Scheuring UJ et al.
A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (> 55 years) patients with Philadelphia chromosome-positive (Ph+/BCR-ABL+) acute lymphoblastic leukemia (ALL) (CSTI571ADE 10).
Ann Hematol 2003;
82: 716-720
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.